Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia

被引：21
|
作者：
Parellada, Eduard [1 ]
Velligan, Dawn I. [2 ]
Emsley, Robin [3 ]
Kissling, Werner [4 ]
机构：
[1] Univ Barcelona, Hosp Clin Barcelona, Dept Psychiat, Clin Schizophrenia Program PEC, E-08036 Barcelona, Spain
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA
[3] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Psychiat, ZA-7500 Cape Town, South Africa
[4] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherap, D-81675 Munich, Germany
来源：
SCHIZOPHRENIA RESEARCH AND TREATMENT | 2012年 / 2012卷
关键词：
D O I：
10.1155/2012/318535
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Johnston, Karen
    Sliwa, Jennifer Kern
    Bossie, Cynthia A.
    Kim, Edward
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2019, 57 (11) : 5 - 5
  • [32] A Randomized Controlled Trial of Long-Acting Injectable Risperidone vs Continuation on Oral Atypical Antipsychotics for First-Episode Schizophrenia Patients: Initial Adherence Outcome
    Weiden, Peter J.
    Schooler, Nina R.
    Weedon, Jeremy C.
    Elmouchtari, Abdel
    Sunakawa, Ayako
    Goldfinger, Stephen M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (10) : 1397 - 1406
  • [33] Long-acting injectable antipsychotics: shall the last be first?
    Stahl, Stephen M.
    CNS SPECTRUMS, 2014, 19 (01) : 3 - 5
  • [34] The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
    Brissos, Sofia
    Ruiz-Veguilla, Miguel
    Taylor, David
    Balanza-Martinez, Vicent
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2014, 4 (05) : 198 - 219
  • [35] Long-acting injectable versus oral antipsychotics for schizophrenia reply
    Kishimoto, Taishiro
    Hagi, Katsuhiko
    Kurokawa, Shunya
    Kane, John M.
    Correll, Christoph U.
    LANCET PSYCHIATRY, 2021, 8 (07): : 567 - 567
  • [36] What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?
    Stroup, T. Scott
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (11) : 1261 - 1262
  • [37] The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence
    Correll, Christoph U.
    Citrome, Leslie
    Haddad, Peter M.
    Lauriello, John
    Olfson, Mark
    Calloway, Stephen M.
    Kane, John M.
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 : 3 - +
  • [38] Impact of long-acting injectable antipsychotics on the illness progression in schizophrenia
    Saiz, P. A.
    EUROPEAN PSYCHIATRY, 2015, 30 (08) : S50 - S50
  • [39] Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
    Parellada, Eduard
    Bioque, Miquel
    CNS DRUGS, 2016, 30 (08) : 689 - 701
  • [40] Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia
    Eduard Parellada
    Miquel Bioque
    CNS Drugs, 2016, 30 : 689 - 701
12345